ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States?

American Journal of Surgery

Volumn 199, Issue 2, 2010, Pages 189-198

  Famakinwa, Olatokunbo M ^a   Roman, Sanziana A ^a   Wang, Tracy S ^b   Sosa, Julie Ann ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

American Thyroid Association guidelines; Differentiated thyroid cancer; Lymphadenectomy; Radioactive iodine; Thyroidectomy

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER STAGING; CROSS-SECTIONAL STUDY; EUROPEAN AMERICAN; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE; RADIOISOTOPE THERAPY; THYROID CANCER; THYROIDECTOMY; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BENCHMARKING; CROSS-SECTIONAL STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; IODINE RADIOISOTOPES; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SOCIETIES, MEDICAL; THYROID NEOPLASMS; THYROIDECTOMY; UNITED STATES;

EID: 74549167389     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.04.022     Document Type: Article

References (39)

1. Grubbs E.G., Rich T.A., Li G., et al. Recent advances in thyroid cancer. Curr Probl Surg 45 (2008) 156-250
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
3. Elaraj D.M., and Clark O.H. Changing management in patients with papillary thyroid cancer. Curr Treat Options Oncol 8 (2007) 305-313
4. Shaha A. Treatment of thyroid cancer based on risk groups. J Surg Oncol 94 (2006) 683-691
5. Hay I.D. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol 94 (2006) 692-700
6. Van Nostrand D., and Wartofsky L. Radioiodine in the treatment of thyroid cancer. Endocrinol Metab Clin N Am 36 (2007) 807-822
7. Sywak M., Cornford L., Roach P., et al. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140 (2006) 1000-1007
8. White M.L., Gauger P.G., and Doherty G.M. Central lymph node dissection in differentiated thyroid cancer. World J Surg 31 (2007) 895-904
9. Low T.H., Delbridge L., Sidhu S., et al. Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer. Ann Surg Oncol 15 (2008) 2827-2832
10. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 109-142
11. AACE/AAES Medical/Surgical Guidelines for Clinical Practice: Management of Thyroid Carcinoma. Endocr Pract 7 (2001) 202-220
12. Pacini F., Schlumberger M., Dralle H., et al., European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154 (2006) 787-803
13. British Thyroid Association, Royal College of Physicians. Guidelines for the management of thyroid cancer. Report of the Thyroid Cancer Guidelines Update Group. 2nd ed. (2007), Royal College of Physicians, London
14. American Head and Neck Society. Practice guidelines: thyroid. http://www.headandneckcancer.org/clinicalresources/docs/diffthyroid.php Accessed July 25, 2008
15. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp Accessed October 10, 2008
16. Gharib H., Papini E., and Pashcke R. Thyroid nodules: a review of current guidelines, practices, and prospects. Eur J Endocrinol 159 (2008) 493-505
17. Vidal-Trecan G.M., Pazart L.H., and Massol J.A. A method for guideline development: assessing practical feasibility and adaptation of thyroid nodule guidelines. J Eval Clin Pract 5 (1999) 189-198
18. Hundahl S.A., Cady B., Cunningham M.P., et al. ; US and German Thyroid Cancer Study Group. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer 89 (2000) 202-217
19. Van den Bruel A., Moreno-Reyes R., Bex M., et al. Is the management of thyroid nodules and differentiated thyroid cancer in accordance with recent consensus guidelines?. Results of a national survey. Clin Endocrinol 68 (2008) 599-604
20. Ries L.A.G., Melbert D., Krapcho M., et al. SEER cancer statistics review, 1975-2005, National Cancer Institute. http://seer.cancer.gov/csr/1975_2005/
21. AJCC cancer staging manual. 5th ed. (1997), Lippincott-Raven, Philadelphia
22. Fritz A., Percy C., Jack A., et al. International classification of diseases for oncology. 3rd ed (2000), World Health Organization, Geneva, Switzerland
23. Studnicki J., Schapira D.V., Bradham D.D., et al. Response to the National Cancer Institute Alert. The effect of practice guidelines on two hospitals in the same medical community. Cancer 72 (1993) 2986-2992
24. Mullan F. Wrestling with variation: an interview with Jack Wennberg. Health Aff (Millwood) Suppl Web Excl (2004) VAR73-80
25. Lazovich D., Solomon C.C., Thomas D.B., et al. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86 (1999) 628-637
26. White J., Morrow M., Moughan J., et al. Compliance with breast-conservation standards for patients with early-stage breast carcinoma. Cancer 97 (2003) 893-904
27. Sosa J.A., Mehta P.J., Wang T.S., et al. Racial disparities in clinical and economic outcomes from thyroidectomy. Ann Surg 246 (2007) 1083-1091
28. Sosa J.A., Mehta P.J., Wang T.S., et al. A population-based study of outcomes from thyroidectomy in aging Americans: at what cost?. J Am Coll Surg 206 (2008) 1097-1105
29. Mahadevia P.J., Sosa J.A., Levine M.A., et al. Clinical management of primary hyperparathyroidism and thresholds for surgical referral: a national study examining concordance between practice patterns and consensus panel recommendations. Endocr Pract 9 (2003) 494-503
30. Sosa J.A., Powe N.R., Levine M.A., et al. Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons. J Clin Endocrinol Metab 83 (1998) 2658-2665
31. Kouvouraki M.A., Greer M., Sharma S., et al. Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery. Surgery 139 (2006) 527-534
32. Bennedbaek F.N., and Hegedüs L. Management of the solitary thyroid nodule: results of a North American study. J Clin Endocrinol Metab 85 (2000) 2493-2498
33. Bonnema S.J., Bennedbaek F.N., Wiersinga W.M., et al. Management of the nontoxic multinodular goiter: a European questionnaire study. Clin Endocrinol 53 (2000) 5-12
34. Bennedbaek F.N., Perrild H., and Hegedüs L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol 50 (2001) 357-363
35. Bonnema S.J., Bennedbaek F.N., Ladenson P.W., et al. Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 87 (2002) 112-117
36. Walsh J.P., Ryan S.A., Lisewski D., et al. Differences between endocrinologists and endocrine surgeons in management of the solitary thyroid nodule. Clin Endocrinol 66 (2007) 844-853
37. Doherty G.M. Invited commentary: routine central neck lymph node dissection for thyroid carcinoma. Surgery 140 (2006) 1007-1008
38. Henry J.F., Gramatica L., Denizot A., et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 383 (1998) 167-169
39. National Cancer Institute. SEER: Surveillance, Epidemiology, and End Results Program. http://www.seer.cancer.gov/about/SEER_brochure.pdf Accessed September 21, 2009